Scientists discover a new way to prevent secondary breast cancer

byInstitute of Cancer ResearchCredit: Pixabay/CC0 Public DomainScientists have discovered why breast cancer cells that have spread to the lungs may "wake up" following years of sleep,

Updated on: December 27,2023

Scientists discover a new way to prevent secondary breast cancer

byInstitute of Cancer ResearchCredit: Pixabay/CC0 Public DomainScientists have discovered why breast cancer cells that have spread to the lungs may "wake up" following years of sleep,

Updated on:December 27,2023

Discovery unveils promising anticancer drug targeting KRAS protein

byVirginia Commonwealth UniversityKRB-456 inhibits the growth in vivo of orthotopic mt KRAS tumors derived from pancreatic cancer patients. Tumor biopsies from pancreatic cancer patient G160 wer

Updated on: December 30,2023

Discovery unveils promising anticancer drug targeting KRAS protein

byVirginia Commonwealth UniversityKRB-456 inhibits the growth in vivo of orthotopic mt KRAS tumors derived from pancreatic cancer patients. Tumor biopsies from pancreatic cancer patient G160 wer

Updated on:December 30,2023

Revealing one of the mechanisms by which thyroid cancer becomes resistant to lenvatinib-a

by Shinshu UniversityThe EGFR-mediated pathway, which is not targeted by lenvatinib, is activated for survival in thyroid cancer cells under the potent inhibition of the VEGFR and FGFR families by len

Updated on: December 26,2023

Revealing one of the mechanisms by which thyroid cancer becomes resistant to lenvatinib-a

by Shinshu UniversityThe EGFR-mediated pathway, which is not targeted by lenvatinib, is activated for survival in thyroid cancer cells under the potent inhibition of the VEGFR and FGFR families by len

Updated on:December 26,2023

Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was

Updated on: January 04,2024

Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was

Updated on:January 04,2024

How genetic therapies transformed the lives of sickle cell patients

Credit: CC0 Public DomainTheir stories are divided into before and after. First, those long years of pain which flooded every moment—school, relationships, work.And then—after agonizing treatments—wha

Updated on: March 27,2024

How genetic therapies transformed the lives of sickle cell patients

Credit: CC0 Public DomainTheir stories are divided into before and after. First, those long years of pain which flooded every moment—school, relationships, work.And then—after agonizing treatments—wha

Updated on:March 27,2024

Fat fuels aggressive brain cancers

byCardiff UniversityGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Fat is powering tumour growth in brain cancer, finds

Updated on: December 18,2023

Fat fuels aggressive brain cancers

byCardiff UniversityGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Fat is powering tumour growth in brain cancer, finds

Updated on:December 18,2023

Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA UCLA Health-led study found a combination of interventions of one-on-one telehealth coaching, peer support forums, and a

Updated on: May 16,2024

Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA UCLA Health-led study found a combination of interventions of one-on-one telehealth coaching, peer support forums, and a

Updated on:May 16,2024

Racial disparities in lung cancer start with research

by Melba NewsomeCredit: Pixabay/CC0 Public DomainDuring a routine visit to the Good Samaritan Clinic in Morganton, North Carolina, in 2018, Herbert Buff casually mentioned that he sometimes had troubl

Updated on: December 22,2023

Racial disparities in lung cancer start with research

by Melba NewsomeCredit: Pixabay/CC0 Public DomainDuring a routine visit to the Good Samaritan Clinic in Morganton, North Carolina, in 2018, Herbert Buff casually mentioned that he sometimes had troubl

Updated on:December 22,2023

Tiny surgical robots could transform detection and treatment of cancers

byUniversity of LeedsRobotic platform for peripheral lung tumor intervention based on magnetic tentacles. Credit: STORM Lab, University of LeedsA tiny robot which can travel deep into the lungs

Updated on: January 08,2024

Tiny surgical robots could transform detection and treatment of cancers

byUniversity of LeedsRobotic platform for peripheral lung tumor intervention based on magnetic tentacles. Credit: STORM Lab, University of LeedsA tiny robot which can travel deep into the lungs

Updated on:January 08,2024

Energy stress triggers PFKL-dependent lipid droplet-mitochondria tethering and β-oxidation to support tumor growth

Updated on: September 15,2024

Energy stress triggers PFKL-dependent lipid droplet-mitochondria tethering and β-oxidation to support tumor growth

Updated on:September 15,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on: April 28,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on:April 28,2024

Overlooked strategy shows promise for treating KRAS-mutated colon cancer

Updated on: June 14,2025

Overlooked strategy shows promise for treating KRAS-mutated colon cancer

Updated on:June 14,2025